Xiidra 00078-0911
Generic: Lifitegrast
Product NDC
00078-0911- Manufacturer
- Novartis Pharmaceuticals Corporation
- Dosage Form
- Solution/ Drops
- Route
- Ophthalmic
- Product Type
- Human Prescription Drug
- Marketing Start
- July 11, 2016
- Listing Expires
- December 31, 2026
- Application
- NDA208073
Need to source Xiidra? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lifitegrast | 50 mg/mL |
Drug Class
Lymphocyte Function-Associated Antigen-1 Antagonist [EPC]Lymphocyte Function-Associated Antigen-1 Antagonist [EPC]Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]
Packaging Options(2)
12 POUCH in 1 CARTON (0078-0911-12) / 5 AMPULE in 1 POUCH (0078-0911-05) / .2 mL in 1 AMPULE
4 POUCH in 1 CARTON (0078-0911-94) / 5 AMPULE in 1 POUCH (0078-0911-95) / .2 mL in 1 AMPULE